Impact of genetic variation of PPARγ in humans

Molecular Genetics and Metabolism

Volumn 83, Issue 1-2, 2004, Pages 93-102

  Meirhaeghe, Aline ^a   Amouyel, Philippe ^a,b  

^a INSTITUT PASTEUR DE LILLE   (France)

^b UNIV LILLE   (France)

Author keywords

Obesity; Polymorphism; PPAR ; Type 2 diabetes

Indexed keywords

ALANINE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE;

CARCINOMA; CARDIOVASCULAR DISEASE; DIABETIC NEPHROPATHY; EXON; GENE INTERACTION; GENE MUTATION; GENE TARGETING; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY;

EID: 4744340732     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymgme.2004.08.014     Document Type: Review

References (88)

1. P. Tontonoz, E. Hu, R.A. Graves, A.I. Budavari, and B.M. Spiegelman mPPARγ2: tissue-specific regulator of an adipocyte enhancer Genes Dev. 8 1994 1224 1234
2. B.M. Spiegelman, and J.S. Flier Adipogenesis and obesity: rounding out the big picture Cell 87 1996 377 389
3. L. Fajas, J.C. Fruchart, and J. Auwerx PPARγ3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoter FEBS Lett. 438 1998 55 60
4. I. Barroso, M. Gurnell, V.E. Crowley, M. Agostini, J.W. Schwabe, M.A. Soos, G.L. Maslen, T.D. Williams, H. Lewis, A.J. Schafer, V.K. Chatterjee, and S. O'Rahilly Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus, and hypertension Nature 402 1999 880 883
5. D.B. Savage, G.D. Tan, C.L. Acerini, S.A. Jebb, M. Agostini, M. Gurnell, R.L. Williams, A.M. Umpleby, E.L. Thomas, J.D. Bell, A.K. Dixon, F. Dunne, R. Boiani, S. Cinti, A. Vidal-Puig, F. Karpe, V.K. Chatterjee, and S. O'Rahilly Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma Diabetes 52 2003 910 917
6. A.K. Agarwal, and A. Garg A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy J. Clin. Endocrinol. Metab. 87 2002 408 411
7. R.A. Hegele, H. Cao, C. Frankowski, S.T. Mathews, and T. Leff PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy Diabetes 51 2002 3586 3590
8. M. Ristow, D. Muller-Wieland, A. Pfeiffer, W. Krone, and C.R. Kahn Obesity associated with a mutation in a genetic regulator of adipocyte differentiation N. Engl. J. Med. 339 1998 953 959
9. A. Hamann, H. Munzberg, P. Buttron, B. Busing, A. Hinney, H. Mayer, W. Siegfried, J. Hebebrand, and H. Greten Missense variants in the human peroxisome proliferator-activated receptor-gamma2 gene in lean and obese subjects Eur. J. Endocrinol. 141 1999 90 92
10. D. Evans, W.A. Mann, J. Heer, U. Michel, D. Wendt, B. Kortner, A. Wolf, and U. Beisiegel Variation in the gene for human peroxisome proliferator activated receptor gamma (PPARgamma) does not play a major role in the development of morbid obesity Int. J. Obes. Relat. Metab. Disord. 24 2000 647 651
11. J. Ek, S.A. Urhammer, T.I. Sorensen, T. Andersen, J. Auwerx, and O. Pedersen Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men Diabetologia 42 1999 892 895
12. J. Terrett, J. Chamberlain, S. Rastan, R. Marshall, R. McGinnis, N. Spurr, E. O'Brien, C. Evans, and A. Rut The Pro-115 → Gln mutation in peroxisome-proliferator-activated receptor (PPAR) gamma2 is extremely rare in a large cohort of US Caucasians Clin. Sci. (Lond.) 99 2000 89 90
13. K. Clement, S. Hercberg, B. Passinge, P. Galan, M. Varroud-Vial, A.R. Shuldiner, B.A. Beamer, G. Charpentier, B. Guy-Grand, P. Froguel, and C. Vaisse The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes Int. J. Obes. Relat. Metab. Disord. 24 2000 391 393
14. M. Bluher, and R. Paschke Analysis of the relationship between PPAR-gamma 2 gene variants and severe insulin resistance in obese patients with impaired glucose tolerance Exp. Clin. Endocrinol. Diabetes 111 2003 85 90
15. A. Meirhaeghe, L. Fajas, N. Helbecque, D. Cottel, P. Lebel, J. Dallongeville, S. Deeb, J. Auwerx, and P. Amouyel A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans Hum. Mol. Genet. 7 1998 435 440
16. F. Orio Jr., G. Matarese, S. Di Biase, S. Palomba, D. Labella, V. Sanna, S. Savastano, F. Zullo, A. Colao, and G. Lombardi Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome J. Clin. Endocrinol. Metab. 88 2003 5887 5892
17. R. Valve, K. Sivenius, R. Miettinen, J. Pihlajamaki, A. Rissanen, S.S. Deeb, J. Auwerx, M. Uusitupa, and M. Laakso Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women J. Clin. Endocrinol. Metab. 84 1999 3708 3712
18. X.L. Wang, J. Oosterhof, and N. Duarte Peroxisome proliferator-activated receptor gamma C161 → T polymorphism and coronary artery disease Cardiovasc. Res. 44 1999 588 594
19. C.J. Yen, B.A. Beamer, C. Negri, K. Silver, K.A. Brown, D.P. Yarnall, D.K. Burns, J. Roth, and A.R. Shuldiner Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPARγ) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation Biochem. Biophys. Res. Commun. 241 1997 270 274
20. S.S. Deeb, L. Fajas, M. Nemoto, J. Pihlajamaki, L. Mykkanen, J. Kuusisto, M. Laakso, W. Fujimoto, and J. Auwerx A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity Nat. Genet. 20 1998 284 287
21. K. Hara, T. Okada, K. Tobe, K. Yasuda, Y. Mori, H. Kadowaki, R. Hagura, Y. Akanuma, S. Kimura, C. Ito, and T. Kadowaki The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes Biochem. Biophys. Res. Commun. 271 2000 212 216
22. H. Mori, H. Ikegami, Y. Kawaguchi, S. Seino, N. Yokoi, J. Takeda, I. Inoue, Y. Seino, K. Yasuda, T. Hanafusa, K. Yamagata, T. Awata, T. Kadowaki, K. Hara, N. Yamada, T. Gotoda, N. Iwasaki, Y. Iwamoto, T. Sanke, K. Nanjo, Y. Oka, A. Matsutani, E. Maeda, and M. Kasuga The Pro12 → Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes Diabetes 50 2001 891 894
23. W.D. Li, J.H. Lee, and R.A. Price The peroxisome proliferator-activated receptor gamma 2 Pro12Ala mutation is associated with early onset extreme obesity and reduced fasting glucose Mol. Genet. Metab. 70 2000 159 161
24. J.A. Douglas, M.R. Erdos, R.M. Watanabe, A. Braun, C.L. Johnston, P. Oeth, K.L. Mohlke, T.T. Valle, C. Ehnholm, T.A. Buchanan, R.N. Bergman, F.S. Collins, M. Boehnke, and J. Tuomilehto The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences Diabetes 50 2001 886 890
25. P. Poulsen, G. Andersen, M. Fenger, T. Hansen, S.M. Echwald, A. Volund, H. Beck-Nielsen, O. Pedersen, and A. Vaag Impact of two common polymorphisms in the PPARgamma gene on glucose tolerance and plasma insulin profiles in monozygotic and dizygotic twins: thrifty genotype, thrifty phenotype, or both? Diabetes 52 2003 194 198
26. R.A. Hegele, H. Cao, S.B. Harris, B. Zinman, A.J. Hanley, and C.M. Anderson Peroxisome proliferator-activated receptor-gamma2 P12A and type 2 diabetes in Canadian Oji-Cree J. Clin. Endocrinol. Metab. 85 2000 2014 2019
27. D. Evans, J. de Heer, C. Hagemann, D. Wendt, A. Wolf, U. Beisiegel, and W.A. Mann Association between the P12A and c1431t polymorphisms in the peroxisome proliferator activated receptor gamma (PPAR gamma) gene and type 2 diabetes Exp. Clin. Endocrinol. Diabetes 109 2001 151 154
28. V.I. Lindi, M.I. Uusitupa, J. Lindstrom, A. Louheranta, J.G. Eriksson, T.T. Valle, H. Hamalainen, P. Ilanne-Parikka, S. Keinanen-Kiukaanniemi, M. Laakso, and J. Tuomilehto Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study Diabetes 51 2002 2581 2586
29. F.P. Mancini, O. Vaccaro, L. Sabatino, A. Tufano, A.A. Rivellese, G. Riccardi, and V. Colantuoni Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes Diabetes 48 1999 1466 1468
30. J. Ringel, S. Engeli, A. Distler, and A.M. Sharma Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus Biochem. Biophys. Res. Commun. 254 1999 450 453
31. B. Zietz, N. Barth, D. Spiegel, G. Schmitz, J. Scholmerich, and A. Schaffler Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPARγ2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients Exp. Clin. Endocrinol. Diabetes 110 2002 60 66
32. M.T. Malecki, J. Frey, T. Klupa, J. Skupien, M. Walus, W. Mlynarski, and J. Sieradzki The Pro12Ala polymorphism of PPARgamma2 gene and susceptibility to type 2 diabetes mellitus in a Polish population Diabetes Res. Clin. Pract. 62 2003 105 111
33. E.Y. Oh, K.M. Min, J.H. Chung, Y.K. Min, M.S. Lee, K.W. Kim, and M.K. Lee Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-gamma2 in Korean diabetic and obese subjects J. Clin. Endocrinol. Metab. 85 2000 1801 1804
34. Y.L. Muller, C. Bogardus, B.A. Beamer, A.R. Shuldiner, and L.J. Baier A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians Diabetes 52 2003 1864 1871
35. D. Altshuler, J.N. Hirschhorn, M. Klannemark, C.M. Lindgren, M.C. Vohl, J. Nemesh, C.R. Lane, S.F. Schaffner, S. Bolk, C. Brewer, T. Tuomi, D. Gaudet, T.J. Hudson, M. Daly, L. Groop, and E.S. Lander The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes Nat. Genet. 26 2000 76 80
36. A.S. Doney, B. Fischer, J.E. Cecil, K. Boylan, F.E. McGuigan, S.H. Ralston, A.D. Morris, and C.N. Palmer Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes Diabetologia 47 2004 555 558
37. D.E. Kelley, and L.J. Mandarino Fuel selection in human skeletal muscle in insulin resistance: a reexamination Diabetes 49 2000 677 683
38. L.M. Chuang, C.A. Hsiung, Y.D. Chen, L.T. Ho, W.H. Sheu, D. Pei, C.H. Nakatsuka, D. Cox, R.E. Pratt, H.H. Lei, and T.Y. Tai Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance J. Mol. Med. 79 2001 656 664
39. S. Li, W. Chen, S.R. Srinivasan, E. Boerwinkle, and G.S. Berenson The peroxisome proliferator-activated receptor-gamma2 gene polymorphism (Pro12Ala) beneficially influences insulin resistance and its tracking from childhood to adulthood: the Bogalusa Heart Study Diabetes 52 2003 1265 1269
40. M. Hara, S.Y. Alcoser, A. Qaadir, K.K. Beiswenger, N.J. Cox, and D.A. Ehrmann Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro(12)Ala polymorphism in the PPARgamma gene J. Clin. Endocrinol. Metab. 87 2002 772 775
41. J.L. Gonzalez Sanchez, M. Serrano Rios, P.C. Fernandez, M. Laakso, and M.T. Martinez Larrad Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population Eur. J. Endocrinol. 147 2002 495 501
42. L. Frederiksen, K. Brodbaek, M. Fenger, T. Jorgensen, K. Borch-Johnsen, S. Madsbad, and S.A. Urhammer Comment: studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome J. Clin. Endocrinol. Metab. 87 2002 3989 3992
43. H. Knoblauch, A. Busjahn, B. Muller-Myhsok, H.D. Faulhaber, H. Schuster, R. Uhlmann, and F.C. Luft Peroxisome proliferator-activated receptor gamma gene locus is related to body mass index and lipid values in healthy nonobese subjects Arterioscler. Thromb. Vasc. Biol. 19 1999 2940 2944
44. A. Meirhaeghe, L. Fajas, N. Helbecque, D. Cottel, J. Auwerx, S.S. Deeb, and P. Amouyel Impact of the peroxisome proliferator activated receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus Int. J. Obes. Relat. Metab. Disord. 24 2000 195 199
45. B.A. Beamer, C.J. Yen, R.E. Andersen, D. Muller, D. Elahi, L.J. Cheskin, R. Andres, J. Roth, and A.R. Shuldiner Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations Diabetes 47 1998 1806 1808
46. S.A. Cole, B.D. Mitchell, W.C. Hsueh, P. Pineda, B.A. Beamer, A.R. Shuldiner, A.G. Comuzzie, J. Blangero, and J.E. Hixson The Pro12Ala variant of peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) is associated with measures of obesity in Mexican Americans Int. J. Obes. Relat. Metab. Disord. 24 2000 522 524
47. A. Doney, B. Fischer, D. Frew, A. Cumming, D.M. Flavell, M. World, H.E. Montgomery, D. Boyle, A. Morris, and C.N. Palmer Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weight BMC Genet. 3 2002 21
48. J. Pihlajamaki, R. Miettinen, R. Valve, L. Karjalainen, L. Mykkanen, J. Kuusisto, S. Deeb, J. Auwerx, and M. Laakso The Pro12A1a substitution in the peroxisome proliferator activated receptor gamma 2 is associated with an insulin-sensitive phenotype in families with familial combined hyperlipidemia and in nondiabetic elderly subjects with dyslipidemia Atherosclerosis 151 2000 567 574
49. Y. Mori, H. Kim-Motoyama, T. Katakura, K. Yasuda, H. Kadowaki, B.A. Beamer, A.R. Shuldiner, Y. Akanuma, Y. Yazaki, and T. Kadowaki Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor gamma 2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men Biochem. Biophys. Res. Commun. 251 1998 195 198
50. M.M. Swarbrick, C.M. Chapman, B.M. McQuillan, J. Hung, P.L. Thompson, and J.P. Beilby A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity Eur. J. Endocrinol. 144 2001 277 282
51. S. Masud, and S. Ye Effect of the peroxisome proliferator activated receptor-gamma gene Pro12Ala variant on body mass index: a meta-analysis J. Med. Genet. 40 2003 773 780
52. S. Korhonen, S. Heinonen, M. Hiltunen, S. Helisalmi, M. Hippelainen, R. Koivunen, J.S. Tapanainen, and M. Laakso Polymorphism in the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome Hum. Reprod. 18 2003 540 543
53. S.M. Herrmann, J. Ringel, J.G. Wang, J.A. Staessen, and E. Brand Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study Diabetes 51 2002 2653 2657
54. M.L. Caramori, L.H. Canani, L.A. Costa, and J.L. Gross The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes Diabetes 52 2003 3010 3013
55. D. Bishop-Bailey Peroxisome proliferator-activated receptors in the cardiovascular system Br. J. Pharmacol. 129 2000 823 834
56. P.M. Ridker, N.R. Cook, S. Cheng, H.A. Erlich, K. Lindpaintner, J. Plutzky, and R.Y. Zee Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction Arterioscler. Thromb. Vasc. Biol. 23 2003 859 863
57. C. La Vecchia, E. Negri, A. Decarli, and S. Franceschi Diabetes mellitus and colorectal cancer risk Cancer Epidemiol. Biomarkers Prev. 6 1997 1007 1010
58. M.J. Reginato, S.L. Krakow, S.T. Bailey, and M.A. Lazar Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma J. Biol. Chem. 273 1998 1855 1858
59. S. Tomita, H. Kawamata, J. Imura, F. Omotehara, Y. Ueda, and T. Fujimori Frequent polymorphism of peroxisome proliferator activated receptor gamma gene in colorectal cancer containing wild-type K-ras gene Int. J. Mol. Med. 9 2002 485 488
60. E. Mueller, P. Sarraf, P. Tontonoz, R.M. Evans, K.J. Martin, M. Zhang, C. Fletcher, S. Singer, and B.M. Spiegelman Terminal differentiation of human breast cancer through PPAR gamma Mol. Cell 1 1998 465 470
61. M. Pignatelli, C. Cocca, A. Santos, and A. Perez-Castillo Enhancement of BRCA1 gene expression by the peroxisome proliferator-activated receptor gamma in the MCF-7 breast cancer cell line Oncogene 22 2003 5446 5450
62. A. Memisoglu, S.E. Hankinson, J.E. Manson, G.A. Colditz, and D.J. Hunter Lack of association of the codon 12 polymorphism of the peroxisome proliferator-activated receptor gamma gene with breast cancer and body mass Pharmacogenetics 12 2002 597 603
63. Y. Segawa, R. Yoshimura, T. Hase, T. Nakatani, S. Wada, Y. Kawahito, T. Kishimoto, and H. Sano Expression of peroxisome proliferator-activated receptor (PPAR) in human prostate cancer Prostate 51 2002 108 116
64. T. Kubota, K. Koshizuka, E.A. Williamson, H. Asou, J.W. Said, S. Holden, I. Miyoshi, and H.P. Koeffler Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo Cancer Res. 58 1998 3344 3352
65. D. Paltoo, K. Woodson, P. Taylor, D. Albanes, J. Virtamo, and J. Tangrea Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) gene and risk of prostate cancer among men in a large cancer prevention study Cancer Lett. 191 2003 67 74
66. J. Schneider, J. Kreuzer, A. Hamann, P.P. Nawroth, and K.A. Dugi The proline 12 alanine substitution in the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower lipoprotein lipase activity in vivo Diabetes 51 2002 867 870
67. J. Masugi, Y. Tamori, H. Mori, T. Koike, and M. Kasuga Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis Biochem. Biophys. Res. Commun. 268 2000 178 182
68. M. Koch, K. Rett, E. Maerker, A. Volk, K. Haist, M. Deninger, W. Renn, and H.U. Haring The PPARgamma2 amino acid polymorphism Pro 12 Ala is prevalent in offspring of Type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects Diabetologia 42 1999 758 762
69. S. Jacob, M. Stumvoll, R. Becker, M. Koch, M. Nielsen, K. Loblein, E. Maerker, A. Volk, W. Renn, B. Balletshofer, F. Machicao, K. Rett, and H.U. Haring The PPARgamma2 polymorphism pro12Ala is associated with better insulin sensitivity in the offspring of type 2 diabetic patients Horm. Metab. Res. 32 2000 413 416
70. M. Stumvoll, H.G. Wahl, K. Loblein, R. Becker, F. Machicao, S. Jacob, and H. Haring Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene is associated with increased antilipolytic insulin sensitivity Diabetes 50 2001 876 881
71. O. Vaccaro, F.P. Mancini, G. Ruffa, L. Sabatino, C. Iovine, M. Masulli, V. Colantuoni, and G. Riccardi Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR) gamma2 gene in healthy individuals Clin. Endocrinol. (Oxf.) 57 2002 481 486
72. C. Thamer, M. Haap, A. Volk, E. Maerker, R. Becker, O. Bachmann, F. Machicao, H.U. Haring, and M. Stumvoll Evidence for greater oxidative substrate flexibility in male carriers of the Pro 12 Ala polymorphism in PPARgamma2 Horm. Metab. Res 34 2002 132 136
73. I. Simon, J. Vendrell, C. Gutierrez, J.M. Fernandez-Real, I. Vendrell, L. Gallart, R. Fontova, and C. Richart Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma is associated with increased leptin levels in women with type-2 diabetes mellitus Horm. Res. 58 2002 143 149
74. Y. Yamamoto, H. Hirose, K. Miyashita, K. Nishikai, I. Saito, M. Taniyama, M. Tomita, and T. Saruta PPAR(gamma)2 gene Pro12Ala polymorphism may influence serum level of an adipocyte-derived protein, adiponectin, in the Japanese population Metabolism 51 2002 1407 1409
75. M. Kolehmainen, M.I. Uusitupa, E. Alhava, M. Laakso, and H. Vidal Effect of the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor (PPAR) gamma2 gene on the expression of PPARgamma target genes in adipose tissue of massively obese subjects J. Clin. Endocrinol. Metab. 88 2003 1717 1722
76. J. Rieusset, C. Chambrier, K. Bouzakri, E. Dusserre, J. Auwerx, J.P. Riou, M. Laville, and H. Vidal The expression of the p85alpha subunit of phosphatidylinositol 3-kinase is induced by activation of the peroxisome proliferator-activated receptor gamma in human adipocytes Diabetologia 44 2001 544 554
77. W.S. Yang, C.A. Hsiung, L.T. Ho, Y.T. Chen, C.T. He, J.D. Curb, J. Grove, T. Quertermous, Y.D. Chen, S.S. Kuo, and L.M. Chuang Genetic epistasis of adiponectin and PPARgamma2 genotypes in modulation of insulin sensitivity: a family-based association study Diabetologia 46 2003 977 983
78. W.C. Hsueh, S.A. Cole, A.R. Shuldiner, B.A. Beamer, J. Blangero, J.E. Hixson, J.W. MacCluer, and B.D. Mitchell Interactions between variants in the beta3-adrenergic receptor and peroxisome proliferator-activated receptor-gamma2 genes and obesity Diabetes Care 24 2001 672 677
79. E. Bakopanos, and J.E. Silva Thiazolidinediones inhibit the expression of beta3-adrenergic receptors at a transcriptional level Diabetes 49 2000 2108 2115
80. J. Robitaille, J.P. Despres, L. Perusse, and M.C. Vohl The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Quebec Family Study Clin. Genet. 63 2003 109 116
81. A. Memisoglu, F.B. Hu, S.E. Hankinson, J.E. Manson, V. De, I.W.C. Willett, and D.J. Hunter Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass Hum. Mol. Genet. 12 2003 2923 2929
82. J. Luan, P.O. Browne, A.H. Harding, D.J. Halsall, S. O'Rahilly, V.K. Chatterjee, and N.J. Wareham Evidence for geneâ€"nutrient interaction at the PPARgamma locus Diabetes 50 2001 686 689
83. P.W. Franks, J. Luan, P.O. Browne, A.H. Harding, S. O'Rahilly, V.K. Chatterjee, and N.J. Wareham Does peroxisome proliferator-activated receptor gamma genotype (Pro12ala) modify the association of physical activity and dietary fat with fasting insulin level? Metabolism 53 2004 11 16
84. D.J. Barker, P.D. Winter, C. Osmond, B. Margetts, and S.J. Simmonds Weight in infancy and death from ischaemic heart disease Lancet 2 1989 577 580
85. C.N. Hales, D.J. Barker, P.M. Clark, L.J. Cox, C. Fall, C. Osmond, and P.D. Winter Fetal and infant growth and impaired glucose tolerance at age 64 BMJ 303 1991 1019 1022
86. J.G. Eriksson, V. Lindi, M. Uusitupa, T.J. Forsen, M. Laakso, C. Osmond, and D.J. Barker The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on insulin sensitivity and insulin metabolism interact with size at birth Diabetes 51 2002 2321 2324
87. A. Meirhaeghe, L. Fajas, F. Gouilleux, D. Cottel, N. Helbecque, J. Auwerx, and P. Amouyel A functional polymorphism in a STAT5B site of the human PPAR gamma 3 gene promoter affects height and lipid metabolism in a French population Arterioscler. Thromb. Vasc. Biol 23 2003 289 294
88. N. Kubota, Y. Terauchi, H. Miki, H. Tamemoto, T. Yamauchi, K. Komeda, S. Satoh, R. Nakano, C. Ishii, T. Sugiyama, K. Eto, Y. Tsubamoto, A. Okuno, K. Murakami, H. Sekihara, G. Hasegawa, M. Naito, Y. Toyoshima, S. Tanaka, K. Shiota, T. Kitamura, T. Fujita, O. Ezaki, S. Aizawa, and T. Kadowaki PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance Mol. Cell 4 1999 597 609